Citation Impact

Citing Papers

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
2013
Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.
1983
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
The Effect of Protein Restriction on the Progression of Renal Insufficiency
1989
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
2009
Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials
2008
Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure
1993
Kidney stones: pathophysiology and medical management
2006 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Prevalence of CKD and Its Relationship to eGFR-Related Genetic Loci and Clinical Risk Factors in the SardiNIA Study Cohort
2014
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
1996 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
What do we know about chronic kidney disease in India: first report of the Indian CKD registry
2012
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Renal sodium retention in cirrhosis: Tubular site and relation to hepatic dysfunction
1988
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population
2012
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
1999 Standout
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
The modification of diet in renal disease study group
1991
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials
1997
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Calcium oxalate nephrolithiasis: Defective oxalate transport
1991
Vitamin D Deficiency
2007 Standout
Effect of Restricting Dietary Protein on the Progression of Renal Failure in Patients with Insulin-Dependent Diabetes Mellitus
1991
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
The Modification of Diet in Renal Disease Study
1989
Thiazide Treatment for Calcium Urolithiasis in Patients with Idiopathic Hypercalciuria
1992
Cardiovascular effects of gliptins
2013
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells
2012
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
1996
The Pathogenesis and Treatment of Kidney Stones
1992
Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis*
2013
International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk
2006
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
2015
A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones
1993 Standout
Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up
2004
Chronic kidney disease: global dimension and perspectives
2013 Standout
Long-Term Complications of Diabetes Mellitus
1993 Standout
Rationale for Fixed-Dose Combinations in the Treatment of Hypertension
2002
Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency
1989
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Mechanisms of tubulointerstitial fibrosis
2004
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Periodontal diseases
2005 Standout
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria
2002 Standout
Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study
1996
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency
1991
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Mechanisms of Bone Metastasis
2004 Standout
Demographic and geographic variability of kidney stones in the United States
1994
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
2004
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR
1989
Assessing the progression of renal disease in clinical studies
1991
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
The Role of Hemodynamic Factors in the Initiation and Progression of Renal Disease
1985
The Effect of a Keto Acid–Amino Acid Supplement to a Restricted Diet on the Progression of Chronic Renal Failure
1984
Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites: An overview with emphasis on pathogenesis
1986
Genes and Gene Polymorphisms Associated with Periodontal Disease
2003
Hypoglycemic agents and potential anti-inflammatory activity
2016
Comparative Study of the Effect of ACE-Inhibitors and Other Antihypertensive Agents on Proteinuria in Diabetic Patients
1994
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
1983
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Altered renal calcium handling in hypercalcemia of malignancy.
1991
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
1984
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
2007
The Primary Stone Event: A New Hypothesis Involving a Vascular Etiology
2004
Controlled low protein diets in chronic renal insufficiency: meta-analysis.
1992
Estimating Glomerular Filtration Rate in Older People
2014
Nephron adaptation to renal injury or ablation
1985
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
2000 StandoutScience
Randomized Trial of Allopurinol in the Prevention of Calcium Oxalate Calculi
1986
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Measurement of renal function in chronic renal disease
1990
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
2013
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
1984 Standout

Works of Angela D’Angelo being referenced

Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study
2009
Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects
2010
Oral Glucose Tolerance Test Effects on Endothelial Inflammation Markers in Healthy Subjects and Diabetic Patients
2009
Effects of 1 Year of Treatment with Pioglitazone or Rosiglitazone Added to Glimepiride on Lipoprotein (a) and Homocysteine Concentrations in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Multicenter, Randomized, Double-Blind, Controlled Clinical Trial
2006
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
2009
Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients
2010
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis
2003
Genetics of hypercalciuria and calcium nephrolithiasis: From the rare monogenic to the common polygenic forms
2004
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load
2010
Risk for Renal Failure in Nephrolithiasis
2001
Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes
2011
ORIGINAL ARTICLE: Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin
2010
Circulating Levels of Soluble Receptor for Advanced Glycation End Products in Alzheimer Disease and Vascular Dementia
2005
Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome
2006
Prevalence of CKD in Northeastern Italy
2010
Pioglitazone Compared to Glibenclamide on Lipid Profile and Inflammation Markers in Type 2 Diabetic Patients During an Oral Fat Load
2011
Exenatide Versus Glibenclamide in Patients with Diabetes
2010
<sup>125</sup>I-Iothalamate and Creatinine Clearances in Patients with Chronic Renal Disease
1979
Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol
1981
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure.
1983
The renal handling of calcium in normal subjects and in renal disease.
1971
Renal Acidification Defects in Patients with Recurrent Calcium Nephrolithiasis
1985
Renal Handling Of Sodium and Water in Early Chronic Liver Disease
1981
Long-term follow-up evaluation in HCV chronic hepatitis treated with alpha-2b interferon. A comparison of two protocols.
1994
Captopril in the treatment of hypertension in type I and type II diabetic patients.
1986
Possible link between vitamin D and hyperoxaluria in patients with renal stone disease
1993
Association studies of genetic polymorphisms and complex disease
2000
Effects of Nateglinide and Glibenclamide on Prothrombotic Factors in Naieve Type 2 Diabetic Patients Treated with Metformin: A 1-Year, Double-Blind, Randomized Clinical Trial
2007
Effects of dietary protein and phosphorus restriction on the progression of early renal failure
1982
TGFβ1 induces epithelial–mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture
2006
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients
2001
Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men
2005
Silent chronic kidney disease epidemic seen from Europe: designing strategies for clinical management of the early stages.
2005
Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients with Type 2 Diabetes not Controlled with Metformin
2013
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
2005
Rankless by CCL
2026